RhumbLine Advisers’s Zevra Therapeutics ZVRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$733K Buy
2025
Q1
$559K Buy
2024
Q4
$568K Buy
2024
Q3
$399K Buy
2024
Q2
$279K Buy
2024
Q1
$280K Buy
2023
Q4
$309K Buy
2023
Q3
$220K Buy
2023
Q2
$220K Buy
2022
Q2
Sell
2022
Q1
$163K Sell
2021
Q4
$289K Buy
2021
Q3
$305K Buy
2021
Q2
$408K Buy